Amy Morgan obtained her MSN degree in the Acute Care Nurse Practitioner Program from UIC in 2009 and initially practiced as a Nurse Practitioner in Pulmonary and Critical Care. Currently, she works as a Nurse Practitioner at Northwestern Medicine for a division that specializes in stem cell transplants for autoimmune diseases including Multiple Sclerosis, Scleroderma, Chronic Inflammatory Demyelinating Polyneuropathy and Crohn's Disease.
Amy Morgan supervises clinical rotations for graduate students in the Adult-Gerontology Acute Care Nurse Practitioner program.
Burt,R., Oliveira, M.C., Sanjiv, S., Moraes, D.A., Simoes,B., Gheorghiade, M., Schroeder, J., Ruderman, E., Farge, D., Chai, Z.J., Marjanovic, Z., Jain, S., Morgan, A., Milanetti, F., Han, X., Jovanovic, B., Helenowski, I.B., Voltarelli, J. (2013). Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis. The Lancet, 381(9872), 1116-1124.
Jain, S., Gozdziak, P., Morgan, A., Burt, R.K. (2013). Remission of Crohn’s disease after cord blood transplantation for leukocyte adhesion deficiency type 1. Bone Marrow Transplantation, 48, 1006-1007.
Burt, R., Shah, S., Dill, K., Grant, T., Gheorghiade, M., Schroeder, J., Craig, R., Hirano, I.,Marshall, K., Ruderman, E., Borko, J., Milanetti, F., Jain, S., Boyce, K., Morgan, A., Carr, J., & Barr, W. (2011). Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomized phase 2 trial. The Lancet, 378(9790), 498-450.